Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SABAHAT BOKHARI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1831288158
CMS profile
472805
Location
ALLENTOWN, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$282,137.67

199 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Alnylam Pharmaceuticals Inc. $131,596.76 90
BridgeBio Pharma, Inc. $65,357.32 46
AstraZeneca Pharmaceuticals LP $47,508.98 38
PFIZER INC. $20,086.86 11
E.R. Squibb & Sons, L.L.C. $15,635.00 12
Alexion Pharmaceuticals, Inc. $1,925.00 1
Tempus AI, Inc $27.75 1

Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SABAHAT BOKHARI

NPI 1831288158 · CMS profile ID 472805

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ALLENTOWN, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831288158?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SABAHAT BOKHARI, NPI 1831288158, CMS profile ID 472805. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831288158?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SABAHAT BOKHARI, NPI 1831288158, CMS profile ID 472805. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831288158?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SABAHAT BOKHARI, NPI 1831288158, CMS profile ID 472805, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1831288158?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

199 matching records · $282,137.67 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 199 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–199 of 199.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alnylam Pharmaceuticals Inc. $10,500.0005/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759586 CMS
Alnylam Pharmaceuticals Inc. $250.6205/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759588 CMS
Alnylam Pharmaceuticals Inc. $68.3805/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759590 CMS
AstraZeneca Pharmaceuticals LP $86.3305/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207238163 CMS
PFIZER INC. $2,500.0005/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1229013527 CMS
AstraZeneca Pharmaceuticals LP $2,150.0005/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1206787432 CMS
AstraZeneca Pharmaceuticals LP $75.6005/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206155910 CMS
AstraZeneca Pharmaceuticals LP $102.4005/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206224604 CMS
E.R. Squibb & Sons, L.L.C. $3.7804/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184897206 CMS
E.R. Squibb & Sons, L.L.C. $12.9704/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184897208 CMS
AstraZeneca Pharmaceuticals LP $113.9604/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206212855 CMS
Alexion Pharmaceuticals, Inc. $1,925.0004/28/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1202985052 CMS
Alnylam Pharmaceuticals Inc. $29.1404/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759596 CMS
Alnylam Pharmaceuticals Inc. $50.0004/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759604 CMS
Alnylam Pharmaceuticals Inc. $49.9904/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759606 CMS
Alnylam Pharmaceuticals Inc. $75.0004/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759608 CMS
Alnylam Pharmaceuticals Inc. $49.9904/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759610 CMS
Alnylam Pharmaceuticals Inc. $409.0804/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759592 CMS
Alnylam Pharmaceuticals Inc. $486.7804/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759594 CMS
Alnylam Pharmaceuticals Inc. $75.0004/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759598 CMS
Alnylam Pharmaceuticals Inc. $49.9904/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759600 CMS
Alnylam Pharmaceuticals Inc. $124.8404/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759602 CMS
AstraZeneca Pharmaceuticals LP $2,150.0004/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1207315340 CMS
Alnylam Pharmaceuticals Inc. $329.1604/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759582 CMS
Alnylam Pharmaceuticals Inc. $645.7004/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759584 CMS
PFIZER INC. $21.7704/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228980206 CMS
Alnylam Pharmaceuticals Inc. $63.0004/02/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759578 CMS
Alnylam Pharmaceuticals Inc. $3,750.0004/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759580 CMS
AstraZeneca Pharmaceuticals LP $105.1004/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206914788 CMS
Alnylam Pharmaceuticals Inc. $6,000.0003/28/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759572 CMS
Alnylam Pharmaceuticals Inc. $237.1703/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759574 CMS
Alnylam Pharmaceuticals Inc. $150.0003/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759576 CMS
Alnylam Pharmaceuticals Inc. $938.0003/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759562 CMS
Alnylam Pharmaceuticals Inc. $296.9602/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759566 CMS
Alnylam Pharmaceuticals Inc. $199.0802/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759568 CMS
Alnylam Pharmaceuticals Inc. $145.6302/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759570 CMS
Alnylam Pharmaceuticals Inc. $4,875.0002/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1212759550 CMS
Alnylam Pharmaceuticals Inc. $3,000.0002/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759552 CMS
Alnylam Pharmaceuticals Inc. $158.9702/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212759554 CMS
Alnylam Pharmaceuticals Inc. $3,750.0002/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759560 CMS
Alnylam Pharmaceuticals Inc. $2,250.0002/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212759564 CMS
E.R. Squibb & Sons, L.L.C. $23.8002/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184897196 CMS
AstraZeneca Pharmaceuticals LP $2,150.0002/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1207087160 CMS
Alnylam Pharmaceuticals Inc. $124.9901/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759558 CMS
AstraZeneca Pharmaceuticals LP $53.2001/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206397486 CMS
AstraZeneca Pharmaceuticals LP $114.4801/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207039538 CMS
Alnylam Pharmaceuticals Inc. $28.6101/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212759556 CMS
Alnylam Pharmaceuticals Inc. $2,467.5001/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1212759700 CMS
AstraZeneca Pharmaceuticals LP $2,150.0001/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1206580016 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,162.77 35
PY2020 $13,600.00 5
PY2021 $26,005.24 6
PY2022 $5,464.90 7
PY2023 $14,001.51 14
PY2024 $193,871.30 191
PY2025 $282,137.67 199

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $138,890.76 19
PY2024 Principal investigator $39,035.10 4
PY2022 Principal investigator $4,500.00 4
PY2021 Principal investigator $15,027.00 7
PY2019 Principal investigator $15,763.75 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Cleerly, Inc. $1,144.52 12/12/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146046
Principal investigator 1 Cleerly, Inc. $1,426.36 12/02/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146040
Principal investigator 1 Eidos Therapeutics, Inc. $28,230.39 11/07/2025 Non-covered Recipient Entity
Rutgers The State University
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial) No dispute reported 06/30/2026 1250868759
Principal investigator 1 Cleerly, Inc. $7,882.68 11/05/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146034
Principal investigator 1 Eidos Therapeutics, Inc. $747.50 10/16/2025 Non-covered Recipient Entity
Rutgers The State University
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial) No dispute reported 06/30/2026 1250868753
Principal investigator 1 Eidos Therapeutics, Inc. $975.00 10/16/2025 Non-covered Recipient Entity
Rutgers The State University
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial) No dispute reported 06/30/2026 1250868755
Principal investigator 1 Cleerly, Inc. $2,596.88 10/08/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146024
Principal investigator 1 Cleerly, Inc. $9,987.90 09/05/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146016
Principal investigator 1 Cleerly, Inc. $6,783.66 08/04/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146010
Principal investigator 1 Eidos Therapeutics, Inc. $5,151.51 07/30/2025 Non-covered Recipient Entity
Rutgers The State University
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial) No dispute reported 06/30/2026 1250868757
Principal investigator 1 Cleerly, Inc. $9,556.56 07/08/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241146000
Principal investigator 1 Cleerly, Inc. $14,547.52 06/02/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145992
Principal investigator 1 Cleerly, Inc. $6,115.98 05/06/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145986
Principal investigator 1 Cleerly, Inc. $3,106.74 04/07/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145972
Principal investigator 1 Cleerly, Inc. $8,810.88 03/10/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145964
Principal investigator 1 GE HEALTHCARE $5,000.00 03/05/2025 Non-covered Recipient Entity
TRUSTEES OF COLUMBIA UNIVERSITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY
Not supplied No dispute reported 06/30/2026 1244366883
Principal investigator 1 Cleerly, Inc. $1,092.00 03/03/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145976
Principal investigator 1 Cleerly, Inc. $6,161.48 02/10/2025 Non-covered Recipient Entity
Rutgers State University
TRANSFORM No dispute reported 06/30/2026 1241145956
Principal investigator 1 AstraZeneca UK Limited $19,573.20 01/17/2025 Non-covered Recipient Entity
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis No dispute reported 06/30/2026 1185555191